Norway caps exenatide prescribing to 12 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
March 2025 — Vol. 2, No. 3
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, March 2025Xi'an export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
A supplier suspends shipping to the United Kingdom after 13 consecutive customs detentions
The route did not close because of a rule about peptides.
The quiet end of Calder Vale Peptides of Skipton
A proper account of an operation that existed, and of what closing it cost.
Medutest result on a Wuhan orforglipron lot lands 3.1 points below the supplier’s figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
TRIUMPH-1 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The 24-day notice: how a compounding wind-down works in Australia
The document is four pages. Three of them are about dates.
From the floor in Shanghai: 8 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Independent analysis puts a HJ exenatide lot at 98.4%, against 97.3% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Inspectors cite the consolidator trading as Meridian Freight Partners over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 28-day notice: how a compounding wind-down works in Canada
The document is four pages. Three of them are about dates.
VendorInvestigate result on a Hong Kong retatrutide lot lands 2.9 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Japan pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
Changsha export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a MKM liraglutide lot at 96.2%, against 94.9% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
From the floor in Hangzhou: 24 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
SURPASS-2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
PeptideMeter result on a Hangzhou exenatide lot lands 3.5 points below the supplier’s figure
The result is unremarkable. What the report omits is not.